Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-29 Sale |
2022-10-03 7:32 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $10.86 | $173,749 | 1,121,117 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-16 6:58 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
10,000 | $13.36 | $133,635 | 836,614 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-02 7:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,066 | $10.35 | $404,199 | 9,785,757 (Indirect Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 6:35 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
30,000 | $12.61 | $378,444 | 846,614 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 6:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $12.6 | $201,637 | 1,227,117 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-05 7:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,325 | $9.4865 | $373,058 | 9,843,210 (Indirect Direct) |
View |
| 2022-07-07 Sale |
2022-07-08 6:36 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,614 | $9.0535 | $358,647 | 9,882,535 (Indirect Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 8:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,190 | $6.1063 | $257,625 | 9,909,513 (Indirect Direct) |
View |
| 2022-05-04 Sale |
2022-05-06 8:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
55,330 | $6.4685 | $357,900 | 18,002,176 (Indirect Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 9:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,675 | $6.1405 | $495,381 | 19,174,770 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 9:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,108 | $6.1701 | $494,275 | 26,290,299 (Indirect Direct) |
View |
| 2022-04-18 Sale |
2022-04-20 9:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,336 | $6.8302 | $261,842 | 10,185,580 (Indirect Direct) |
View |
| 2022-04-14 Sale |
2022-04-18 9:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
37,017 | $7.5541 | $279,630 | 10,223,916 (Indirect Direct) |
View |
| 2022-04-08 Sale |
2022-04-12 8:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,420 | $6.5954 | $259,991 | 10,260,933 (Indirect Direct) |
View |
| 2022-04-07 Sale |
2022-04-11 8:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,218 | $6.5409 | $256,520 | 10,300,353 (Indirect Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 7:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,326 | $6.7609 | $259,119 | 10,321,071 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-07 9:15 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
36,972 | $7.425 | $274,518 | 10,359,397 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-03 Option Award |
2022-10-05 9:10 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
920 | $0 | 7,672,697 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 9:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
977 | $0 | 13,624,213 (Direct) |
View |
| 2022-09-29 Exercise |
2022-10-03 7:32 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $0 | 1,121,117 (Direct) |
View |
| 2022-09-29 Exercise |
2022-10-03 7:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $1.06 | 1,121,117 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 6:58 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $2.22 | 836,614 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 6:58 pm |
N/A 2030-03-20 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
5,000 | $0 | 836,614 (Direct) |
View |
| 2022-09-01 Conversion |
2022-09-02 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,785,757 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-02 7:24 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,785,757 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-02 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,785,757 (Direct) |
View |
| 2022-08-15 Tax Withholding |
2022-08-17 6:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
613 | $12.96 | 846,614 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 6:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
25,000 | $2.22 | 846,614 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 6:35 pm |
N/A 2030-03-20 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Business Officer |
25,000 | $0 | 846,614 (Direct) |
View |
| 2022-08-15 Tax Withholding |
2022-08-17 6:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,453 | $12.96 | 1,227,117 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 6:34 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $0 | 1,227,117 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 6:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
16,000 | $1.06 | 1,227,117 (Direct) |
View |
| 2022-08-15 Tax Withholding |
2022-08-17 6:33 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
1,065 | $12.96 | 587,637 (Direct) |
View |
| 2022-08-15 Tax Withholding |
2022-08-17 6:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,751 | $12.96 | 536,078 (Direct) |
View |
| 2022-08-04 Conversion |
2022-08-05 7:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,843,210 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 7:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,843,210 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 7:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,843,210 (Direct) |
View |
| 2022-07-08 Other |
2022-07-12 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
2,420 | $0 | 22,985 (Direct) |
View |
| 2022-07-07 Conversion |
2022-07-08 6:36 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,882,535 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-08 6:36 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,882,535 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-08 6:36 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,882,535 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,409 | $0 | 5,122,068 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,224 | $0 | 31,476 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:48 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,631 | $0 | 156,149 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:47 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,186 | $0 | 7,671,777 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 5:45 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,260 | $0 | 13,623,236 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:19 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
54,435 | $0 | 7,719,381 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:18 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
54,435 | $0 | 5,184,727 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:16 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
54,435 | $0 | 599,797 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:14 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
54,435 | $0 | 54,435 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:12 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
54,435 | $0 | 607,996 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 8:10 pm |
2023-06-14 2032-06-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
54,435 | $0 | 603,042 (Direct) |
View |
| 2022-06-02 Conversion |
2022-06-06 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,909,513 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 8:54 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,909,513 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,909,513 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:20 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
870 | $5.67 | 104,386 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
832 | $5.67 | 121,110 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
1,069 | $5.67 | 588,702 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,458 | $5.67 | 206,560 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,764 | $5.67 | 506,208 (Direct) |
View |
| 2022-05-04 Conversion |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 18,002,176 (Direct) |
View |
| 2022-04-28 Conversion |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,024 | $2.48 | 19,174,770 (Direct) |
View |
| 2022-04-21 Conversion |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
54,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $2.48 | 26,290,299 (Direct) |
View |
| 2022-04-25 Gift |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
12,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-18 Conversion |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,185,580 (Direct) |
View |
| 2022-04-14 Conversion |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,223,916 (Direct) |
View |
| 2022-04-08 Conversion |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,260,933 (Direct) |
View |
| 2022-04-07 Conversion |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,300,353 (Direct) |
View |
| 2022-04-06 Conversion |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,321,071 (Direct) |
View |
| 2022-04-05 Conversion |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,359,397 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
1,382 | $0 | 13,621,976 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 7:25 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,300 | $0 | 7,652,446 (Direct) |
View |